Pharmacology
The word pharmacology comes from the Greek term pharmakon, meaning drug or poison. This same root appears in pharmakos, a ritual scapegoat exiled in ancient Greece. Early human history shows crude drugs used since prehistory as preparations of natural substances. Opium from poppies served as medicine before 1100 BCE. Avicenna wrote The Canon of Medicine during the Middle Ages to document herbal treatments. Peter of Spain and John of St Amand also compiled commentaries on earlier medical texts. These works formed early pharmacopoeias listing plant extracts and their uses. Crude drugs remained unrefined and often contained adulterated substances alongside active ingredients.
Pharmacodynamics examines how drugs affect biological systems through receptor binding and dose-response relationships. Pharmacokinetics studies what the body does to a drug including liberation absorption distribution metabolism and excretion. Rudolf Buchheim established the first pharmacology department at the University of Tartu in 1847. He recognized the need to understand therapeutic effects scientifically rather than attributing them to extraordinary chemical powers. William Withering advanced clinical pharmacology in the 18th century through detailed observations of digitalis effects. Modern techniques like ligand binding assays developed in 1945 allowed quantification of drug binding affinity. Organ bath preparations connected tissue samples to recording devices such as myographs for physiological analysis. These tools transformed vague explanations into measurable data about molecular mechanisms and targets.
Neuropharmacology focuses on central and peripheral nervous system interactions with specific neurotransmitters like dopamine serotonin and acetylcholine. Psychopharmacology treats mental disorders using antidepressants while incorporating behavioral neuroscience approaches. Immunopharmacology studies immune system responses to pharmaceutical compounds. Cardiovascular renal and endocrine pharmacology address organ-specific drug actions. Pharmacogenomics applies genomic technologies to characterize drugs related to an organism's entire genome. Pharmacomicrobiomics examines how gut microbiome variations affect drug disposition and toxicity. Epigenetic therapy introduces persistent changes to phenotype without altering DNA sequences directly. Network pharmacology combines systems biology principles to study complex drug-target interactions across biological networks. These specialized branches allow precise targeting of diseases affecting individual genes or metabolic pathways.
Drug discovery identifies lead compounds intended to treat disease through structural activity relationship analysis. Chemists create analogues to maximize medicinal effects after initial identification. This process takes anywhere from a few years to over a decade and costs significantly. Only one out of every 5000 potential medicines reaches the open market according to industry statistics. Testing phases extend up to six years before marketing approval occurs in the United States. The Food and Drug Administration requires effectiveness demonstrated in at least two trials against placebo or competitors. Safety criteria demand extensive animal testing across several species plus controlled human trials. Pharmaceutical companies obtain patents preventing other firms from producing identical medicines for set time periods. Costs often exceed one billion US dollars per approved drug due to these lengthy requirements. Companies research demand carefully before spending company funds on development projects.
The Food and Drug Administration regulates pharmaceuticals in the United States under federal guidelines established by law. The Prescription Drug Marketing Act of 1987 governs safety and effectiveness standards for prescription drugs. European Medicines Agency enforces similar regulations within the European Union alongside national pharmacopoeias. The Medicines and Healthcare products Regulatory Agency performs comparable functions in the United Kingdom. National Drug Codes administered by FDA provide unique identifiers for all marketed medications. Health Canada issues Drug Identification Numbers under its Food and Drugs Act framework. World Health Organization maintains Anatomical Therapeutic Chemical Classification System codes globally. These regulatory bodies ensure drugs meet therapeutic benefit thresholds while minimizing toxic side effects. Approval processes require demonstration that drugs perform better than existing treatments or placebos.
Photopharmacology activates and deactivates drugs using light energy to change molecular shape reversibly. This approach prevents environmental pollution and reduces unwanted side effects through precise temporal control. Epigenetic therapy offers alternative master switches to gene therapy introducing persistent phenotypic changes. Psychoplastogens produce profound neuroplasticity regulation effects at therapeutic doses. Pharmacometabolomics measures metabolite levels in bodily fluids to predict drug metabolism profiles. Environmental pharmacology studies how used pharmaceuticals affect ecosystems after elimination from human bodies. Drug tolerance develops when repeated administration causes loss of efficacy over time. Grey matter preservation occurs in ADHD patients receiving psychostimulants at appropriate dosages. These emerging fields expand beyond classical ligand binding models into complex network interactions and personalized medicine strategies.
Common questions
What is the origin of the word pharmacology?
The word pharmacology comes from the Greek term pharmakon meaning drug or poison. This same root appears in pharmakos a ritual scapegoat exiled in ancient Greece.
When did Rudolf Buchheim establish the first pharmacology department?
Rudolf Buchheim established the first pharmacology department at the University of Tartu in 1847. He recognized the need to understand therapeutic effects scientifically rather than attributing them to extraordinary chemical powers.
How many potential medicines reach the open market out of every 5000 candidates?
Only one out of every 5000 potential medicines reaches the open market according to industry statistics. Testing phases extend up to six years before marketing approval occurs in the United States.
Which agency regulates pharmaceuticals in the United States under federal guidelines?
The Food and Drug Administration regulates pharmaceuticals in the United States under federal guidelines established by law. The Prescription Drug Marketing Act of 1987 governs safety and effectiveness standards for prescription drugs.
What does photopharmacology do to activate and deactivate drugs?
Photopharmacology activates and deactivates drugs using light energy to change molecular shape reversibly. This approach prevents environmental pollution and reduces unwanted side effects through precise temporal control.